Accordingly, a new strategy for prevention and treatment of depression has emerged targeting inflammation (the pro-inflammatory cytokines and the pathways involved in their upregulation and overactivation) to ameliorate signs of depression through reducing IDO-1. Here, IDO1 is linked to depressive symptom measurement.